Search
Business Practice
View More
Business
Development
Legal
Policy
Practice
Regulatory
Business
Development
Legal
Policy
Practice
Regulatory
News
All News
Product Approvals and Launches
All News
Product Approvals and Launches
Media
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Stakeholder Summit
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Stakeholder Summit
Compendia
Bone Health
Dermatology
Diabetes
Gastroenterology
Hematology
Immunology
Neurology
Oncology
Ophthalmology
Rare Disease
Respiratory
Rheumatology
Bone Health
Dermatology
Diabetes
Gastroenterology
Hematology
Immunology
Neurology
Oncology
Ophthalmology
Rare Disease
Respiratory
Rheumatology
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
CME/CE
Resources
Authors
Biosimilar Resources
Interactive Tools
Partners
Polls and Quizzes
Sponsored
WHEN CHOICE ARRIVES: Competition & Consequences
Authors
Biosimilar Resources
Interactive Tools
Partners
Polls and Quizzes
Sponsored
WHEN CHOICE ARRIVES: Competition & Consequences
Subscribe
BIOSIMILAR APPROVALS
Search
Advertisement
Business Practice
See All >
Business
Development
Legal
Policy
Practice
Regulatory
Bringing Oncology Biosimilars to Patients
EP. 1: Patient Awareness of Biosimilars and Loyalty to Branded Drugs
January 24th 2018
EP. 2: Patient Savings From Biosimilars
January 24th 2018
EP. 3: Barriers to Biosimilars for Oncology Patients
January 24th 2018
EP. 4: Biosimilars, Payers, and Formulary Changes
January 24th 2018
EP. 5: The Exceptions Process and its Effect on Patients
January 24th 2018
EP. 6: Patient Education on Coverage for Biologics and Biosimilars
January 24th 2018
EP. 7: Alternative Payment Models and Patient Care
January 24th 2018
EP. 8: The Cost of Biologics and Biosimilars
January 24th 2018
EP. 9: Rebates and Medicare Part D
January 24th 2018
EP. 10: CMS' Changes to Reimbursement for Biosimilars
January 24th 2018
Next >>
Advertisement
Advertisement